Trial intelligence / Profile preview

Duloxetine in women with mixed urinary incontinence

NCT00190814Phase 3Completed

Sponsor
Eli Lilly and Company
Start
Sep 2003
Modality
Small Molecules
Countries
3
01

Overview

A Phase 3 trial of duloxetine in mixed urinary incontinence (MUI), sponsored by Eli Lilly and Company. Started Sep 2003; status: completed.

02

Drugs

duloxetine
03

Conditions

mixed urinary incontinence (MUI)

Beyond the preview

Go deeper on NCT00190814.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00190814.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call